Primary prophylaxis in high-risk patients with lung or gastrointestinal cancers lowered incidence of thromboembolism in a randomized trial.
NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary.
Comments are closed.